Kimberly-Clark reported adjusted earnings per share of $1.82 for the third quarter of 2025, surpassing consensus estimates by $0.07. Revenue came in at $4.15 billion, in line year-over-year but $50 million above forecasts despite a 2.2% headwind from the exit of its private-label diaper business in the U.S. Organic sales climbed 2.5%, driven by a 2.4% volume increase, while portfolio mix and pricing remained stable. Gross margin on an adjusted basis stood at 36.8%, down 170 basis points year-over-year due to tariff-related cost inflation and pricing investments, but supported by robust productivity gains.

In October 2025, Kimberly-Clark unveiled plans to acquire consumer health spin-off Kenvue in a landmark $48.7 billion cash-and-stock transaction. This deal—which represents roughly 2.4 times the company’s most recent twelve-month revenue of about $20 billion—will add leading brands in over-the-counter health and personal care. Management expects the acquisition to enhance annual revenue growth by 1–2 percentage points and generate $500 million in cost synergies by the third year post-close, reinforcing its leadership in the global consumer products market spanning 175 countries.

Kimberly-Clark has increased its dividend for 53 consecutive years, earning status among the elite Dividend Kings. The company’s current annualized dividend of $5.04 per share delivers a yield of 5.1%, more than quadruple the S&P 500 average. With a dividend payout ratio near 85% of net income but supported by strong free cash flow conversion—approximately 80% over the last twelve months—management has signaled continued commitment to returning capital to shareholders even under economic pressure.

During the third quarter of 2025, Allspring Global Investments trimmed its stake by 49.1%, selling 21,259 shares and reducing its holding to 22,001 shares, valued at $2.71 million. Meanwhile, Vanguard increased its position by 14.8%, adding 5.2 million shares to reach 40.4 million shares worth over $5.2 billion. Charles Schwab Investment Management and Geode Capital Management also modestly boosted stakes, underscoring varied institutional perspectives on Kimberly-Clark’s valuation relative to its defensive cash flows and dividend stability.